| (+)-catechin | affects phosphorylation | ISO | RGD:2319 | 6480464 | Catechin affects the phosphorylation of CDK1 protein | CTD | PMID:15134381 |
| (+)-pilocarpine | increases expression | ISO | RGD:2319 | 6480464 | Pilocarpine results in increased expression of CDK1 mRNA | CTD | PMID:14656328 |
| (-)-citrinin | decreases expression | EXP | | 6480464 | Citrinin results in decreased expression of CDK1 protein modified form | CTD | PMID:20929984 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | ISO | RGD:731890 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of CDK1 mRNA | CTD | PMID:20826375 |
| 1,3-dinitrobenzene | decreases expression | ISO | RGD:731890 | 6480464 | 3-dinitrobenzene results in decreased expression of CDK1 protein | CTD | PMID:19477251 |
| 1,3-dinitrobenzene | decreases expression | ISO | RGD:2319 | 6480464 | 3-dinitrobenzene results in decreased expression of CDK1 mRNA | CTD | PMID:22841810 |
| 1-chloro-2,4-dinitrobenzene | affects expression | ISO | RGD:731890 | 6480464 | Dinitrochlorobenzene affects the expression of CDK1 mRNA | CTD | PMID:22302311 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:731890 | 6480464 | Ethinyl Estradiol affects the expression of CDK1 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731890 | 6480464 | Ethinyl Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:16174780 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731890 | 6480464 | Ethinyl Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:12072388 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2319 | 6480464 | Ethinyl Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:16174780 PMID:15576828 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731890 | 6480464 | Ethinyl Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:12072388 more ... |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2319 | 6480464 | Ethinyl Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:15576828 PMID:16174780 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:2319 | 6480464 | Ethinyl Estradiol affects the expression of CDK1 mRNA | CTD | PMID:17351261 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:731890 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:731890 | 6480464 | Ethinyl Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:16174780 more ... |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:16474171 PMID:19167446 |
| 17beta-estradiol | increases expression | ISO | RGD:731890 | 6480464 | Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:20826375 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CDK1 mRNA | CTD | PMID:16474171 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDK1 mRNA | CTD | PMID:15056799 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases phosphorylation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased phosphorylation of CDK1 protein | CTD | PMID:22266097 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDK1 protein]; more ... | CTD | PMID:22266097 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731890 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDK1 mRNA | CTD | PMID:15667827 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDK1 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731890 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CDK1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDK1 mRNA | CTD | PMID:15056799 PMID:21802500 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731890 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDK1 mRNA | CTD | PMID:17942748 PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:731890 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CDK1 mRNA | CTD | PMID:15667827 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731890 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK1 mRNA | CTD | PMID:17942748 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2319 | 6480464 | 2,4-dinitrotoluene affects the expression of CDK1 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | ISO | RGD:2319 | 6480464 | 2-Acetylaminofluorene results in increased expression of CDK1 mRNA | CTD | PMID:19167416 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:2319 | 6480464 | Glucosamine results in decreased expression of CDK1 mRNA | CTD | PMID:17109745 |
| 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CDK1 mRNA | CTD | PMID:21179406 |
| 2-nitrofluorene | increases expression | ISO | RGD:2319 | 6480464 | 2-nitrofluorene results in increased expression of CDK1 mRNA | CTD | PMID:15890375 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | ISO | RGD:2319 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDK1 mRNA | CTD | PMID:15890375 |
| 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of CDK1 mRNA | CTD | PMID:16671099 |
| 5-aza-2'-deoxycytidine | increases phosphorylation | EXP | | 6480464 | decitabine results in increased phosphorylation of CDK1 protein | CTD | PMID:19372550 |
| 5-azacytidine | multiple interactions | EXP | | 6480464 | [Azacitidine co-treated with Thalidomide] affects the expression of CDK1 mRNA | CTD | PMID:18720364 |
| 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine analog results in increased expression of CDK1 protein | CTD | PMID:18324645 |
| 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of CDK1 mRNA | CTD | PMID:15205334 PMID:17039268 |
| 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of CDK1 mRNA | CTD | PMID:17039268 PMID:15205334 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | [Leucovorin co-treated with Fluorouracil] results in increased expression of CDK1 mRNA | CTD | PMID:15342418 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of CDK1 mRNA | CTD | PMID:15152939 |
| 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of CDK1 mRNA | CTD | PMID:16557594 |
| 5-formyltetrahydrofolic acid | multiple interactions | EXP | | 6480464 | [Leucovorin co-treated with Fluorouracil] results in increased expression of CDK1 mRNA | CTD | PMID:15342418 |
| afimoxifene | increases expression | EXP | | 6480464 | 4-hydroxytamoxifen results in increased expression of CDK1 mRNA | CTD | PMID:19901195 |
| afimoxifene | decreases response to substance | EXP | | 6480464 | CDK1 results in decreased susceptibility to 4-hydroxytamoxifen | CTD | PMID:21233418 |
| aflatoxin B1 | increases expression | ISO | RGD:2319 | 6480464 | Aflatoxin B1 results in increased expression of CDK1 mRNA | CTD | PMID:15890375 |
| aflatoxin B1 | decreases expression | ISO | RGD:731890 | 6480464 | Aflatoxin B1 results in decreased expression of CDK1 mRNA | CTD | PMID:19770486 |
| alachlor | increases expression | ISO | RGD:2319 | 6480464 | alachlor results in increased expression of CDK1 mRNA | CTD | PMID:12419858 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:2319 | 6480464 | Glucosamine results in decreased expression of CDK1 mRNA | CTD | PMID:17109745 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CDK1 mRNA | CTD | PMID:17138961 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:2319 | 6480464 | Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of CDK1 protein] | CTD | PMID:21964460 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CDK1 protein | CTD | PMID:16517207 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | CDK1 protein affects the reaction [Tretinoin results in increased expression of SCT mRNA] | CTD | PMID:16888198 |
| alpha-hexylcinnamaldehyde | affects expression | ISO | RGD:731890 | 6480464 | hexyl cinnamic aldehyde affects the expression of CDK1 mRNA | CTD | PMID:22302311 |
| amifostine | decreases phosphorylation | EXP | | 6480464 | Amifostine results in decreased phosphorylation of CDK1 protein | CTD | PMID:16628227 |
| amifostine | multiple interactions | EXP | | 6480464 | olomoucine inhibits the reaction [TP53 protein promotes the reaction [Amifostine results in decreased phosphorylation of CDK1 protein]] | CTD | PMID:16628227 |
| apigenin | multiple interactions | EXP | | 6480464 | Apigenin results in increased phosphorylation of and results in decreased activity of CDK1 protein | CTD | PMID:11322924 |
| aristolochic acid | decreases expression | ISO | RGD:2319 | 6480464 | aristolochic acid I results in decreased expression of CDK1 mRNA | CTD | PMID:17483316 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of CDK1 mRNA | CTD | PMID:20654705 |
| arsenite(3-) | decreases expression | ISO | RGD:731890 | 6480464 | arsenite results in decreased expression of CDK1 mRNA | CTD | PMID:18929588 |
| arsenite(3-) | decreases activity | EXP | | 6480464 | arsenite results in decreased activity of CDK1 protein | CTD | PMID:17373649 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [arsenite results in decreased activity of CDK1 protein] | CTD | PMID:17373649 |
| arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of CDK1 protein | CTD | PMID:20083129 |
| atenolol | multiple interactions | ISO | RGD:731890 | 6480464 | Atenolol inhibits the reaction [Isoproterenol results in increased expression of CDK1 mRNA] | CTD | PMID:9593584 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CDK1 protein modified form | CTD | PMID:20850422 |
| benzene | increases phosphorylation | EXP | | 6480464 | Benzene analog results in increased phosphorylation of CDK1 protein | CTD | PMID:15826604 |
| benzo[a]pyrene | affects localization | EXP | | 6480464 | Benzo(a)pyrene affects the localization of CDK1 protein | CTD | PMID:15837074 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CDK1 mRNA | CTD | PMID:21802500 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731890 | 6480464 | Benzo(a)pyrene results in decreased expression of CDK1 mRNA | CTD | PMID:19770486 PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731890 | 6480464 | Benzo(a)pyrene results in decreased expression of CDK1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CDK1 protein modified form | CTD | PMID:20850422 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CDK1 | CTD | PMID:15837074 |
| beta-D-glucosamine | decreases expression | ISO | RGD:2319 | 6480464 | Glucosamine results in decreased expression of CDK1 mRNA | CTD | PMID:17109745 |
| bicalutamide | decreases expression | EXP | | 6480464 | bicalutamide results in decreased expression of CDK1 mRNA | CTD | PMID:15638997 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CDK1 mRNA | CTD | PMID:16474171 |
| bisphenol A | increases expression | ISO | RGD:731890 | 6480464 | bisphenol A results in increased expression of CDK1 mRNA | CTD | PMID:20826375 |
| cadmium atom | multiple interactions | EXP | | 6480464 | Cadmium promotes the reaction [CDKN1A protein binds to CDK1 protein binds to CCNE1 protein] | CTD | PMID:20839231 |
| cadmium atom | decreases expression | ISO | RGD:2319 | 6480464 | Cadmium results in decreased expression of CDK1 protein | CTD | PMID:16730872 |
| cadmium dichloride | decreases expression | ISO | RGD:2319 | 6480464 | Cadmium Chloride results in decreased expression of CDK1 protein | CTD | PMID:16730872 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine results in decreased phosphorylation of and results in increased activity of CDK1 protein | CTD | PMID:11835680 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of CDK1 protein] | CTD | PMID:15975956 |
| caffeine | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [Genistein results in increased phosphorylation of CDK1 protein] | CTD | PMID:19038232 |
| caffeine | multiple interactions | ISO | RGD:731890 | 6480464 | Caffeine inhibits the reaction [Cisplatin results in increased expression of CDK1 protein] | CTD | PMID:9098629 |
| capsaicin | increases expression | ISO | RGD:2319 | 6480464 | Capsaicin results in increased expression of CDK1 mRNA | CTD | PMID:20349343 |
| cefaloridine | decreases expression | ISO | RGD:2319 | 6480464 | Cephaloridine results in decreased expression of CDK1 mRNA | CTD | PMID:18500788 |
| chlorambucil | multiple interactions | EXP | | 6480464 | Chlorambucil analog results in increased phosphorylation of and results in decreased activity of CDK1 protein | CTD | PMID:16861886 |
| choline | multiple interactions | ISO | RGD:731890 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK1 mRNA | CTD | PMID:20938992 |
| chromium(6+) | multiple interactions | ISO | RGD:2319 | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK1 protein] | CTD | PMID:21621607 |
| chromium(6+) | decreases expression | ISO | RGD:2319 | 6480464 | chromium hexavalent ion results in decreased expression of CDK1 protein | CTD | PMID:21621607 |
| ciglitazone | decreases expression | EXP | | 6480464 | ciglitazone results in decreased expression of CDK1 protein | CTD | PMID:21080969 |
| ciglitazone | multiple interactions | EXP | | 6480464 | CREBBP protein inhibits the reaction [ciglitazone results in decreased expression of CDK1 protein]; more ... | CTD | PMID:21080969 |
| ciprofloxacin | increases expression | ISO | RGD:2319 | 6480464 | Ciprofloxacin results in increased expression of CDK1 mRNA; more ... | CTD | PMID:18512786 |
| cisplatin | decreases response to substance | EXP | | 6480464 | CDK1 results in decreased susceptibility to Cisplatin | CTD | PMID:21849418 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of CDK1 protein | CTD | PMID:21592546 PMID:20195699 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of CDK1 protein | CTD | PMID:20195699 PMID:21592546 |
| cisplatin | multiple interactions | EXP | | 6480464 | (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane inhibits the reaction [Cisplatin results in increased phosphorylation of CDK1 protein] | CTD | PMID:20195699 |
| cisplatin | increases expression | ISO | RGD:731890 | 6480464 | Cisplatin results in increased expression of CDK1 protein | CTD | PMID:9098629 |
| cisplatin | increases phosphorylation | EXP | | 6480464 | Cisplatin results in increased phosphorylation of CDK1 protein | CTD | PMID:21592546 |
| cisplatin | multiple interactions | ISO | RGD:731890 | 6480464 | Caffeine inhibits the reaction [Cisplatin results in increased expression of CDK1 protein] | CTD | PMID:9098629 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CDK1 mRNA | CTD | PMID:21603599 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin results in decreased activity of [CCNB1 protein binds to CDK1 protein] | CTD | PMID:21592546 |
| clofibrate | multiple interactions | EXP | | 6480464 | CREBBP protein inhibits the reaction [Clofibrate results in decreased expression of CDK1 protein]; more ... | CTD | PMID:21080969 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CDK1 protein | CTD | PMID:21080969 |
| clotrimazole | decreases expression | EXP | | 6480464 | Clotrimazole results in decreased expression of CDK1 | CTD | PMID:20724915 |
| copper atom | decreases expression | ISO | RGD:2319 | 6480464 | Copper results in decreased expression of CDK1 mRNA | CTD | PMID:19497425 |
| copper atom | multiple interactions | ISO | RGD:731890 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CDK1 mRNA | CTD | PMID:15467011 |
| copper atom | increases expression | ISO | RGD:2319 | 6480464 | Copper results in increased expression of CDK1 mRNA | CTD | PMID:22465980 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CDK1 mRNA | CTD | PMID:20971185 |
| copper(0) | decreases expression | ISO | RGD:2319 | 6480464 | Copper results in decreased expression of CDK1 mRNA | CTD | PMID:19497425 |
| copper(0) | multiple interactions | ISO | RGD:731890 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CDK1 mRNA | CTD | PMID:15467011 |
| copper(0) | increases expression | ISO | RGD:2319 | 6480464 | Copper results in increased expression of CDK1 mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CDK1 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CDK1 mRNA | CTD | PMID:19549813 |
| corticosterone | decreases expression | ISO | RGD:2319 | 6480464 | Corticosterone results in decreased expression of CDK1 mRNA | CTD | PMID:15755911 |
| coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of CDK1 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CDK1 mRNA; more ... | CTD | PMID:19167446 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CDK1 protein | CTD | PMID:16106398 more ... |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CDK1 protein | CTD | PMID:17148446 PMID:19401701 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CDK1 protein | CTD | PMID:16106398 more ... |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CDK1 protein | CTD | PMID:19401701 more ... |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of CDK1 protein | CTD | PMID:19401701 more ... |
| curcumin | decreases expression | ISO | RGD:2319 | 6480464 | Curcumin results in decreased expression of CDK1 mRNA | CTD | PMID:18299980 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | EXP | | 6480464 | SR 144528 inhibits the reaction [Tetrahydrocannabinol results in decreased expression of CDK1 protein]; more ... | CTD | PMID:16818634 |
| Delta(9)-tetrahydrocannabinol | decreases response to substance | EXP | | 6480464 | CDK1 results in decreased susceptibility to Tetrahydrocannabinol | CTD | PMID:16818634 |
| Delta(9)-tetrahydrocannabinol | increases expression | EXP | | 6480464 | Tetrahydrocannabinol results in increased expression of CDK1 mRNA | CTD | PMID:18163980 |
| Delta(9)-tetrahydrocannabinol | decreases expression | EXP | | 6480464 | Tetrahydrocannabinol results in decreased expression of CDK1 protein | CTD | PMID:16818634 |
| Delta(9)-tetrahydrocannabinol | decreases expression | EXP | | 6480464 | Tetrahydrocannabinol results in decreased expression of CDK1 mRNA | CTD | PMID:18454173 |
| dexamethasone | decreases expression | ISO | RGD:2319 | 6480464 | Dexamethasone results in decreased expression of CDK1 mRNA | CTD | PMID:14618091 |
| diallyl disulfide | decreases expression | EXP | | 6480464 | diallyl disulfide results in decreased expression of CDK1 protein | CTD | PMID:16691315 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of CDK1 mRNA | CTD | PMID:20862710 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with Paclitaxel] results in increased activity of CDK1 protein; more ... | CTD | PMID:19781537 |
| diarsenic trioxide | affects expression | EXP | | 6480464 | arsenic trioxide affects the expression of CDK1 mRNA | CTD | PMID:18088464 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of CDK1 protein modified form | CTD | PMID:19825857 |
| diazoxide | increases expression | ISO | RGD:731890 | 6480464 | Isoproterenol results in increased expression of CDK1 mRNA; more ... | CTD | PMID:9593584 |
| diazoxide | multiple interactions | ISO | RGD:731890 | 6480464 | Atenolol inhibits the reaction [Isoproterenol results in increased expression of CDK1 mRNA] | CTD | PMID:9593584 |
| diethylstilbestrol | increases expression | ISO | RGD:2319 | 6480464 | Diethylstilbestrol results in increased expression of CDK1 mRNA | CTD | PMID:15890375 |
| digitoxin | multiple interactions | EXP | | 6480464 | Digitoxin results in decreased expression of [CCNB1 protein binds to CDK1 protein]; more ... | CTD | PMID:22037315 |
| digitoxin | decreases expression | EXP | | 6480464 | Digitoxin analog results in decreased expression of CDK1 protein; more ... | CTD | PMID:22037315 |
| diuron | increases expression | ISO | RGD:2319 | 6480464 | Diuron results in increased expression of CDK1 mRNA | CTD | PMID:21551480 |
| docetaxel anhydrous | increases response to substance | EXP | | 6480464 | CDK1 results in increased susceptibility to docetaxel | CTD | PMID:16928825 |
| docetaxel anhydrous | increases activity | EXP | | 6480464 | docetaxel results in increased activity of CDK1 protein | CTD | PMID:16928825 PMID:14749476 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | bortezomib inhibits the reaction [docetaxel results in increased activity of CDK1 protein] | CTD | PMID:16928825 PMID:14749476 |
| docetaxel anhydrous | multiple interactions | EXP | | 6480464 | bortezomib inhibits the reaction [docetaxel results in increased activity of CDK1 protein] | CTD | PMID:14749476 PMID:16928825 |
| docetaxel anhydrous | increases activity | EXP | | 6480464 | docetaxel results in increased activity of CDK1 protein | CTD | PMID:14749476 PMID:16928825 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Go 6976 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in decreased activity of CDK1 protein] | CTD | PMID:17320279 |
| doxorubicin | multiple interactions | EXP | | 6480464 | [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine co-treated with Doxorubicin] results in decreased phosphorylation of CDK1 protein | CTD | PMID:20826841 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of and results in decreased activity of CDK1 protein | CTD | PMID:15141020 PMID:17320279 |
| doxorubicin | increases phosphorylation | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of CDK1 protein | CTD | PMID:19074854 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CDK1 mRNA | CTD | PMID:15205334 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [RBL2 protein binds to CDK1 promoter] | CTD | PMID:16537896 |
| doxorubicin | multiple interactions | EXP | | 6480464 | CDC25C protein inhibits the reaction [Doxorubicin results in increased phosphorylation of CDK1 protein] | CTD | PMID:19074854 |
| doxorubicin | affects response to substance | EXP | | 6480464 | CDK1 protein affects the susceptibility to Doxorubicin | CTD | PMID:16036217 |
| doxorubicin | affects activity | EXP | | 6480464 | Doxorubicin affects the activity of CDK1 protein | CTD | PMID:16036217 |
| doxorubicin | decreases expression | ISO | RGD:2319 | 6480464 | Doxorubicin results in decreased expression of CDK1 protein | CTD | PMID:15124910 |
| doxorubicin | increases phosphorylation | ISO | RGD:731890 | 6480464 | Doxorubicin results in increased phosphorylation of CDK1 protein | CTD | PMID:15861398 |
| doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CDK1 protein | CTD | PMID:15870702 |
| doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin results in increased phosphorylation of and results in decreased activity of CDK1 protein | CTD | PMID:17320279 PMID:15141020 |
| elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with PD 98059] results in decreased expression of CDK1 mRNA; more ... | CTD | PMID:18583539 |
| elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of CDK1 protein | CTD | PMID:18583539 |
| elemental selenium | decreases expression | EXP | | 6480464 | Selenium deficiency results in decreased expression of CDK1 mRNA | CTD | PMID:11925459 |
| folic acid | multiple interactions | ISO | RGD:731890 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK1 mRNA | CTD | PMID:20938992 |
| fulvestrant | multiple interactions | EXP | | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of CDK1 mRNA | CTD | PMID:19016759 |
| fulvestrant | decreases expression | EXP | | 6480464 | fulvestrant results in decreased expression of CDK1 mRNA | CTD | PMID:19016759 |
| gamma-linolenic acid | decreases expression | EXP | | 6480464 | gamma-Linolenic Acid results in decreased expression of CDK1 protein | CTD | PMID:15318936 |
| genistein | affects expression | EXP | | 6480464 | Genistein affects the expression of CDK1 mRNA | CTD | PMID:18847459 |
| genistein | increases phosphorylation | EXP | | 6480464 | Genistein results in increased phosphorylation of CDK1 protein | CTD | PMID:19038232 |
| genistein | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [Genistein results in increased phosphorylation of CDK1 protein]; more ... | CTD | PMID:19038232 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CDK1 mRNA | CTD | PMID:16474171 |
| genistein | multiple interactions | EXP | | 6480464 | Genistein results in increased phosphorylation of and results in decreased activity of CDK1 protein | CTD | PMID:11322924 |
| genistein | decreases phosphorylation | EXP | | 6480464 | Genistein results in decreased phosphorylation of CDK1 protein | CTD | PMID:10601582 |
| Goe 6976 | multiple interactions | EXP | | 6480464 | Go 6976 inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in decreased activity of CDK1 protein]; more ... | CTD | PMID:17320279 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of CDK1 mRNA | CTD | PMID:21179406 |
| imatinib | multiple interactions | EXP | | 6480464 | [imatinib co-treated with tetraarsenic tetrasulfide] results in decreased expression of CDK1 mRNA | CTD | PMID:19208803 |
| imatinib | decreases expression | EXP | | 6480464 | imatinib results in decreased expression of CDK1 mRNA | CTD | PMID:18190601 PMID:19208803 |
| imatinib | decreases expression | EXP | | 6480464 | imatinib results in decreased expression of CDK1 mRNA | CTD | PMID:19208803 PMID:18190601 |
| isoprenaline | increases expression | ISO | RGD:731890 | 6480464 | Isoproterenol results in increased expression of CDK1 mRNA; more ... | CTD | PMID:9593584 |
| isoprenaline | multiple interactions | ISO | RGD:731890 | 6480464 | Atenolol inhibits the reaction [Isoproterenol results in increased expression of CDK1 mRNA] | CTD | PMID:9593584 |
| kaempferol | multiple interactions | EXP | | 6480464 | kaempferol results in increased phosphorylation of and results in decreased activity of CDK1 protein | CTD | PMID:11322924 |
| ketamine | decreases expression | ISO | RGD:2319 | 6480464 | Ketamine results in decreased expression of CDK1 mRNA | CTD | PMID:20080153 |
| L-ascorbic acid | multiple interactions | ISO | RGD:2319 | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of CDK1 protein] | CTD | PMID:21621607 |
| L-methionine | multiple interactions | ISO | RGD:731890 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK1 mRNA | CTD | PMID:20938992 |
| leptomycin B | decreases expression | EXP | | 6480464 | leptomycin B results in decreased expression of CDK1 mRNA | CTD | PMID:20803015 |
| limonene | increases expression | ISO | RGD:2319 | 6480464 | limonene results in increased expression of CDK1 mRNA | CTD | PMID:12815608 |
| lucanthone | decreases expression | EXP | | 6480464 | Lucanthone results in decreased expression of CDK1 mRNA | CTD | PMID:21148553 |
| luteolin | decreases expression | EXP | | 6480464 | Luteolin results in decreased expression of CDK1 protein | CTD | PMID:22926442 |
| lycopene | decreases expression | EXP | | 6480464 | lycopene results in decreased expression of CDK1 protein | CTD | PMID:17337101 |
| malachite green cation | multiple interactions | ISO | RGD:2319 | 6480464 | [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK1 protein; more ... | CTD | PMID:12616621 |
| mangiferin | increases expression | EXP | | 6480464 | mangiferin results in increased expression of CDK1 mRNA | CTD | PMID:20518311 |
| mechlorethamine | multiple interactions | EXP | | 6480464 | Mechlorethamine results in decreased activity of [CCNB1 protein binds to CDK1 protein]; more ... | CTD | PMID:8463339 |
| mechlorethamine | increases stability | EXP | | 6480464 | Mechlorethamine results in increased stability of CDK1 protein modified form | CTD | PMID:8463339 |
| mechlorethamine | decreases activity | EXP | | 6480464 | Mechlorethamine results in decreased activity of CDK1 protein | CTD | PMID:8463339 |
| melatonin | decreases expression | EXP | | 6480464 | Melatonin results in decreased expression of CDK1 protein; more ... | CTD | PMID:21108658 |
| methamphetamine | increases expression | ISO | RGD:2319 | 6480464 | Methamphetamine results in increased expression of CDK1 mRNA | CTD | PMID:15644446 |
| methapyrilene | increases expression | ISO | RGD:2319 | 6480464 | Methapyrilene results in increased expression of CDK1 mRNA | CTD | PMID:15890375 |
| methyl salicylate | affects expression | ISO | RGD:731890 | 6480464 | methyl salicylate affects the expression of CDK1 mRNA | CTD | PMID:22302311 |
| methylmercury chloride | decreases expression | ISO | RGD:731890 | 6480464 | methylmercuric chloride results in decreased expression of CDK1 mRNA | CTD | PMID:20061341 |
| mifepristone | increases expression | EXP | | 6480464 | Mifepristone results in increased expression of CDK1 mRNA | CTD | PMID:17584828 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Tetrachlorodibenzodioxin results in increased phosphorylation of CDK1 protein] | CTD | PMID:22266097 |
| mifepristone | decreases expression | EXP | | 6480464 | Mifepristone results in decreased expression of CDK1 protein | CTD | PMID:17545545 |
| N-methyl-N-nitrosurea | decreases expression | EXP | | 6480464 | Methylnitrosourea results in decreased expression of CDK1 | CTD | PMID:15870882 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:731890 | 6480464 | Methylnitrosourea results in increased expression of CDK1 protein | CTD | PMID:18593901 |
| N-methyl-N-nitrosurea | increases expression | ISO | RGD:2319 | 6480464 | Methylnitrosourea results in increased expression of CDK1 mRNA | CTD | PMID:16525678 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:731890 | 6480464 | Diethylnitrosamine results in increased expression of CDK1 mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2319 | 6480464 | Diethylnitrosamine results in increased expression of CDK1 mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2319 | 6480464 | [Diethylnitrosamine co-treated with malachite green] results in increased expression of CDK1 mRNA; more ... | CTD | PMID:12616621 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2319 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDK1 mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:731890 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDK1 mRNA] | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:731890 | 6480464 | Diethylnitrosamine results in increased expression of CDK1 protein | CTD | PMID:19887370 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:2319 | 6480464 | Dimethylnitrosamine results in increased expression of CDK1 mRNA | CTD | PMID:15890375 |
| naphthalene | increases expression | ISO | RGD:731890 | 6480464 | naphthalene results in increased expression of CDK1 mRNA | CTD | PMID:18978301 |
| nitroprusside | decreases phosphorylation | EXP | | 6480464 | Nitroprusside results in decreased phosphorylation of CDK1 protein | CTD | PMID:14988404 |
| nonanoic acid | affects expression | ISO | RGD:731890 | 6480464 | pelargonic acid affects the expression of CDK1 mRNA | CTD | PMID:22302311 |
| ochratoxin A | increases expression | ISO | RGD:2319 | 6480464 | ochratoxin A results in increased expression of CDK1 mRNA | CTD | PMID:19717638 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of CDK1 protein modified form | CTD | PMID:22230261 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of CDK1 protein | CTD | PMID:20060447 PMID:22230261 |
| ochratoxin A | multiple interactions | EXP | | 6480464 | MAPK14 protein promotes the reaction [ochratoxin A inhibits the reaction [CDK1 protein binds to CCNB1 protein]]; more ... | CTD | PMID:22230261 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of CDK1 protein; more ... | CTD | PMID:20060447 |
| ochratoxin A | multiple interactions | EXP | | 6480464 | ochratoxin A inhibits the reaction [CCNB1 protein binds to CDK1 protein] | CTD | PMID:20060447 |
| ochratoxin A | increases expression | ISO | RGD:2319 | 6480464 | ochratoxin A results in increased expression of CDK1 protein | CTD | PMID:19237604 |
| ochratoxin A | increases expression | ISO | RGD:2319 | 6480464 | ochratoxin A results in increased expression of CDK1 mRNA | CTD | PMID:19237604 PMID:19717638 |
| okadaic acid | decreases expression | EXP | | 6480464 | Okadaic Acid results in decreased expression of CDK1 mRNA | CTD | PMID:21512803 |
| oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of CDK1 protein | CTD | PMID:15204521 |
| oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of CDK1 protein modified form | CTD | PMID:19735649 |
| oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of CDK1 protein | CTD | PMID:16024531 |
| ozone | increases expression | ISO | RGD:731890 | 6480464 | Ozone results in increased expression of CDK1 mRNA | CTD | PMID:19555225 PMID:12763052 |
| ozone | increases expression | ISO | RGD:731890 | 6480464 | Ozone results in increased expression of CDK1 mRNA | CTD | PMID:12763052 PMID:19555225 |
| paclitaxel | multiple interactions | EXP | | 6480464 | bryostatin 1 inhibits the reaction [Paclitaxel results in increased activity of CDK1 protein] | CTD | PMID:10516758 |
| paclitaxel | multiple interactions | EXP | | 6480464 | [arsenic trioxide co-treated with Paclitaxel] results in increased activity of CDK1 protein; more ... | CTD | PMID:19781537 |
| paclitaxel | increases activity | EXP | | 6480464 | Paclitaxel results in increased activity of CDK1 protein | CTD | PMID:10516758 |
| paclitaxel | multiple interactions | EXP | | 6480464 | [pifithrin co-treated with Paclitaxel] results in decreased phosphorylation of CDK1 protein | CTD | PMID:18516295 |
| paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of CDK1 mRNA | CTD | PMID:18058816 |
| phenobarbital | multiple interactions | ISO | RGD:731890 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CDK1 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:731890 | 6480464 | Phenobarbital results in increased expression of CDK1 mRNA | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:2319 | 6480464 | Phenobarbital results in increased expression of CDK1 mRNA | CTD | PMID:19162173 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:731890 | 6480464 | PPARD protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDK1 mRNA] | CTD | PMID:10866668 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:731890 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CDK1 mRNA | CTD | PMID:10866668 |
| phthalaldehyde | affects expression | ISO | RGD:731890 | 6480464 | o-Phthalaldehyde affects the expression of CDK1 mRNA | CTD | PMID:22302311 |
| piperonyl butoxide | increases expression | ISO | RGD:2319 | 6480464 | Piperonyl Butoxide results in increased expression of CDK1 mRNA | CTD | PMID:15890375 |
| pirinixic acid | decreases phosphorylation | ISO | RGD:731890 | 6480464 | pirinixic acid results in decreased phosphorylation of CDK1 protein | CTD | PMID:19748123 |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 protein | CTD | PMID:17483499 PMID:19176532 |
| pirinixic acid | multiple interactions | ISO | RGD:731890 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of CDK1 protein] | CTD | PMID:17483499 |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:16377806 more ... |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:19176532 more ... |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:18301758 more ... |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:17950772 more ... |
| pirinixic acid | increases expression | ISO | RGD:2319 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:15890375 |
| pirinixic acid | multiple interactions | ISO | RGD:731890 | 6480464 | RXRA protein promotes the reaction [pirinixic acid results in increased expression of CDK1 mRNA]; more ... | CTD | PMID:19176532 |
| pirinixic acid | multiple interactions | ISO | RGD:731890 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CDK1 mRNA] | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 protein | CTD | PMID:19176532 |
| pirinixic acid | increases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in increased expression of CDK1 mRNA | CTD | PMID:19176532 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:731890 | 6480464 | [pirinixic acid co-treated with PPARA] results in increased expression of CDK1 mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:731890 | 6480464 | pirinixic acid results in decreased expression of CDK1 mRNA | CTD | PMID:17426115 |
| potassium bromate | increases phosphorylation | EXP | | 6480464 | potassium bromate results in increased phosphorylation of CDK1 protein | CTD | PMID:20067818 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:731890 | 6480464 | Pregnenolone Carbonitrile results in increased expression of CDK1 mRNA | CTD | PMID:22698814 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:731890 | 6480464 | NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in increased expression of CDK1 mRNA] | CTD | PMID:22698814 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of CDK1 mRNA | CTD | PMID:18070364 |
| propiconazole | increases expression | ISO | RGD:731890 | 6480464 | propiconazole results in increased expression of CDK1 mRNA | CTD | PMID:21278054 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CDK1 mRNA | CTD | PMID:14715546 |
| quercetin | affects expression | ISO | RGD:731890 | 6480464 | Quercetin affects the expression of CDK1 | CTD | PMID:15067354 |
| quercetin | affects phosphorylation | ISO | RGD:731890 | 6480464 | Quercetin affects the phosphorylation of CDK1 protein | CTD | PMID:15067354 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of CDK1 protein | CTD | PMID:19009557 |
| resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CDK1 mRNA | CTD | PMID:19167446 |
| resveratrol | affects phosphorylation | ISO | RGD:2319 | 6480464 | resveratrol affects the phosphorylation of CDK1 protein | CTD | PMID:15134381 |
| resveratrol | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of CDK1 protein] | CTD | PMID:15975956 |
| resveratrol | increases phosphorylation | EXP | | 6480464 | resveratrol results in increased phosphorylation of CDK1 protein | CTD | PMID:15975956 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDK1 protein | CTD | PMID:11577002 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased activity of [CCNB1 protein binds to CDK1 protein] | CTD | PMID:17050787 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK1 protein | CTD | PMID:17050787 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK1 mRNA | CTD | PMID:15767336 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol affects the activity of [CCNB1 protein co-treated with CDK1 protein] | CTD | PMID:12392819 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDK1 mRNA | CTD | PMID:19167446 |
| resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CDK1 protein | CTD | PMID:12392819 |
| selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with PD 98059] results in decreased expression of CDK1 mRNA; more ... | CTD | PMID:18583539 |
| selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of CDK1 protein | CTD | PMID:18583539 |
| selenium atom | decreases expression | EXP | | 6480464 | Selenium deficiency results in decreased expression of CDK1 mRNA | CTD | PMID:11925459 |
| silver atom | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased phosphorylation of CDK1 protein] | CTD | PMID:22546375 |
| silver atom | increases phosphorylation | EXP | | 6480464 | Silver results in increased phosphorylation of CDK1 protein | CTD | PMID:22546375 |
| silver(0) | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased phosphorylation of CDK1 protein] | CTD | PMID:22546375 |
| silver(0) | increases phosphorylation | EXP | | 6480464 | Silver results in increased phosphorylation of CDK1 protein | CTD | PMID:22546375 |
| silver(1+) nitrate | affects expression | EXP | | 6480464 | Silver Nitrate analog affects the expression of CDK1 mRNA | CTD | PMID:22831968 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CDK1 mRNA; more ... | CTD | PMID:20878096 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CDK1 mRNA | CTD | PMID:20878096 PMID:17428261 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of CDK1 mRNA | CTD | PMID:17428261 PMID:20878096 |
| sirolimus | multiple interactions | EXP | | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of CDK1 mRNA | CTD | PMID:19223503 |
| sirolimus | multiple interactions | EXP | | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of CDK1 protein | CTD | PMID:15767555 PMID:19223503 |
| sirolimus | decreases activity | ISO | RGD:2319 | 6480464 | Sirolimus results in decreased activity of CDK1 protein | CTD | PMID:7532117 |
| sirolimus | decreases expression | ISO | RGD:731890 | 6480464 | Sirolimus results in decreased expression of CDK1 protein; more ... | CTD | PMID:19922502 |
| sirolimus | decreases activity | ISO | RGD:731890 | 6480464 | Sirolimus results in decreased activity of CDK1 protein | CTD | PMID:7503980 |
| sirolimus | multiple interactions | ISO | RGD:731890 | 6480464 | Sirolimus inhibits the reaction [IL2 protein results in increased expression of CDK1 mRNA] | CTD | PMID:11355896 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of CDK1 | CTD | PMID:8419408 |
| sirolimus | multiple interactions | EXP | | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of CDK1 mRNA | CTD | PMID:19016759 |
| sirolimus | multiple interactions | EXP | | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased phosphorylation of CDK1 protein | CTD | PMID:15767555 |
| sirolimus | multiple interactions | EXP | | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of CDK1 protein | CTD | PMID:19223503 PMID:15767555 |
| sodium dichromate | increases expression | ISO | RGD:2319 | 6480464 | sodium bichromate results in increased expression of CDK1 mRNA | CTD | PMID:22561333 |
| sodium dichromate | increases expression | ISO | RGD:731890 | 6480464 | sodium bichromate results in increased expression of CDK1 mRNA | CTD | PMID:22155349 |
| sulindac | decreases expression | EXP | | 6480464 | Sulindac results in decreased expression of CDK1 mRNA | CTD | PMID:16273229 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of CDK1 mRNA | CTD | PMID:14699072 |
| tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of CDK1 mRNA | CTD | PMID:15604281 |
| tamoxifen | increases expression | ISO | RGD:2319 | 6480464 | Tamoxifen results in increased expression of CDK1 mRNA | CTD | PMID:12841865 |
| tamoxifen | affects expression | ISO | RGD:731890 | 6480464 | Tamoxifen affects the expression of CDK1 mRNA | CTD | PMID:17555576 |
| temozolomide | multiple interactions | EXP | | 6480464 | temozolomide results in increased phosphorylation of and results in decreased activity of CDK1 protein; more ... | CTD | PMID:15930307 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:731890 | 6480464 | tert-Butylhydroperoxide results in increased expression of CDK1 mRNA | CTD | PMID:15003993 |
| testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of CDK1 mRNA | CTD | PMID:17440010 |
| tetrachloromethane | increases expression | ISO | RGD:731890 | 6480464 | Carbon Tetrachloride results in increased expression of CDK1 mRNA | CTD | PMID:17484886 |
| thalidomide | multiple interactions | EXP | | 6480464 | [Azacitidine co-treated with Thalidomide] affects the expression of CDK1 mRNA | CTD | PMID:18720364 |
| tocopherol | increases expression | ISO | RGD:731890 | 6480464 | Tocopherols results in increased expression of CDK1 mRNA | CTD | PMID:17056531 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol affects the activity of [CCNB1 protein co-treated with CDK1 protein] | CTD | PMID:12392819 |
| trans-resveratrol | affects phosphorylation | ISO | RGD:2319 | 6480464 | resveratrol affects the phosphorylation of CDK1 protein | CTD | PMID:15134381 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of CDK1 protein] | CTD | PMID:15975956 |
| trans-resveratrol | increases phosphorylation | EXP | | 6480464 | resveratrol results in increased phosphorylation of CDK1 protein | CTD | PMID:15975956 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDK1 protein | CTD | PMID:11577002 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in decreased activity of [CCNB1 protein binds to CDK1 protein] | CTD | PMID:17050787 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK1 protein | CTD | PMID:17050787 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of CDK1 mRNA | CTD | PMID:15767336 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of CDK1 mRNA | CTD | PMID:19167446 |
| trans-resveratrol | affects expression | EXP | | 6480464 | resveratrol affects the expression of CDK1 protein | CTD | PMID:12392819 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CDK1 mRNA | CTD | PMID:19167446 |
| trichloroethene | increases expression | ISO | RGD:2319 | 6480464 | Trichloroethylene results in increased expression of CDK1 mRNA | CTD | PMID:17905399 |
| trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of CDK1 mRNA | CTD | PMID:19606018 |
| trimellitic anhydride | increases expression | ISO | RGD:731890 | 6480464 | trimellitic anhydride results in increased expression of CDK1 mRNA | CTD | PMID:19042947 |
| trimellitic anhydride | affects expression | ISO | RGD:731890 | 6480464 | trimellitic anhydride affects the expression of CDK1 mRNA | CTD | PMID:22302311 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CDK1 protein | CTD | PMID:12595159 |
| zidovudine | multiple interactions | EXP | | 6480464 | [Zidovudine co-treated with IFNA1 protein] results in increased expression of CDK1 mRNA | CTD | PMID:20370541 |